Flagship Harbor Advisors LLC Sells 77 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Flagship Harbor Advisors LLC reduced its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 4.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,826 shares of the biotechnology company’s stock after selling 77 shares during the period. Flagship Harbor Advisors LLC’s holdings in Axon Enterprise were worth $1,085,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of the stock. Linden Thomas Advisory Services LLC increased its holdings in shares of Axon Enterprise by 20.5% in the fourth quarter. Linden Thomas Advisory Services LLC now owns 910 shares of the biotechnology company’s stock worth $541,000 after purchasing an additional 155 shares during the last quarter. Geneos Wealth Management Inc. grew its holdings in Axon Enterprise by 630.0% during the 4th quarter. Geneos Wealth Management Inc. now owns 1,847 shares of the biotechnology company’s stock valued at $1,098,000 after buying an additional 1,594 shares in the last quarter. Dynamic Advisor Solutions LLC increased its stake in Axon Enterprise by 35.6% in the 4th quarter. Dynamic Advisor Solutions LLC now owns 3,246 shares of the biotechnology company’s stock worth $1,929,000 after acquiring an additional 852 shares during the last quarter. Harel Insurance Investments & Financial Services Ltd. raised its holdings in shares of Axon Enterprise by 56.2% during the 4th quarter. Harel Insurance Investments & Financial Services Ltd. now owns 5,867 shares of the biotechnology company’s stock worth $3,487,000 after acquiring an additional 2,111 shares in the last quarter. Finally, Zweig DiMenna Associates LLC bought a new position in shares of Axon Enterprise during the 4th quarter valued at approximately $4,606,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise Stock Down 0.9 %

Shares of NASDAQ AXON opened at $604.68 on Tuesday. Axon Enterprise, Inc. has a 12-month low of $247.04 and a 12-month high of $698.67. The stock’s fifty day simple moving average is $617.75 and its two-hundred day simple moving average is $474.21. The stock has a market capitalization of $46.11 billion, a PE ratio of 156.25, a price-to-earnings-growth ratio of 6.09 and a beta of 1.04. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32.

Insider Buying and Selling

In other news, insider Jeffrey C. Kunins sold 21,834 shares of the stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $593.88, for a total transaction of $12,966,775.92. Following the completion of the sale, the insider now owns 154,394 shares in the company, valued at approximately $91,691,508.72. This represents a 12.39 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the sale, the director now owns 6,929 shares in the company, valued at $4,185,601.03. The trade was a 6.10 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 50,545 shares of company stock worth $30,721,337 in the last three months. 6.10% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several research analysts recently commented on the company. TD Cowen began coverage on Axon Enterprise in a research report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price target for the company. JMP Securities boosted their target price on Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research report on Thursday, October 31st. Northland Securities increased their price target on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a report on Monday, November 11th. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and lifted their price objective for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Finally, The Goldman Sachs Group lifted their price target on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research note on Monday. One analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the company. According to MarketBeat, Axon Enterprise has an average rating of “Moderate Buy” and a consensus price target of $524.85.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.